<p>Two novel benzotriazole Cu(II) complexes, [Cu(bmem)(CH<sub>3</sub>O)Cl]<sub>n</sub> (<b>1</b>) and [Cu(btmt)(H<sub>2</sub>O)(SO<sub>4</sub>)]<sub>2</sub> (<b>2</b>), were synthesized and characterized using 1-(benzotriazole-1-methyl)-1-(2-ethylimidazole) (bmem) and 1-(benzotriazole-1-methyl)-1-triazole (btmt) as ligands. X-ray single crystal diffraction analysis indicates that complex <b>1</b> forms a one-dimensional chain structure of a double-nuclear copper unit, while complex <b>2</b> forms a discrete binuclear copper unit. Their antidiabetic activities were thoroughly investigated. The antidiabetic activity assays demonstrated that both complexes exhibited inhibitory effects against α-amylase and α-glycosidase enzymes. Specifically, complex <b>1</b> showed IC<sub>50</sub> values of 2.92 × 10<sup>− 3</sup> M for α-amylase and 2.39 × 10<sup>− 6</sup> M for α-glycosidase, while complex <b>2</b> exhibited IC<sub>50</sub> values of 1.89 × 10<sup>− 3</sup> M and 1.63 × 10<sup>− 6</sup> M, respectively, with complex <b>2</b> displaying a stronger inhibitory effect overall. Furthermore, to evaluate the effects of complexes <b>1</b> and <b>2</b> on glucose metabolism, we treated insulin-resistant (IR) HepG2 cells with each complex. The results demonstrated that complexes <b>1</b> and <b>2</b> enhanced glucose uptake by 1.20-fold and 1.32-fold, respectively, compared to the untreated control.</p>

错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

Two novel benzotriazole Cu(II) complexes: synthesis, structure and antidiabetic activity

  • Xia Wang,
  • Han-Bing Li,
  • Di Cheng,
  • Meng-Meng Cao,
  • Wen-Ke Yang,
  • Tan-Peng Zhou

摘要

Two novel benzotriazole Cu(II) complexes, [Cu(bmem)(CH3O)Cl]n (1) and [Cu(btmt)(H2O)(SO4)]2 (2), were synthesized and characterized using 1-(benzotriazole-1-methyl)-1-(2-ethylimidazole) (bmem) and 1-(benzotriazole-1-methyl)-1-triazole (btmt) as ligands. X-ray single crystal diffraction analysis indicates that complex 1 forms a one-dimensional chain structure of a double-nuclear copper unit, while complex 2 forms a discrete binuclear copper unit. Their antidiabetic activities were thoroughly investigated. The antidiabetic activity assays demonstrated that both complexes exhibited inhibitory effects against α-amylase and α-glycosidase enzymes. Specifically, complex 1 showed IC50 values of 2.92 × 10− 3 M for α-amylase and 2.39 × 10− 6 M for α-glycosidase, while complex 2 exhibited IC50 values of 1.89 × 10− 3 M and 1.63 × 10− 6 M, respectively, with complex 2 displaying a stronger inhibitory effect overall. Furthermore, to evaluate the effects of complexes 1 and 2 on glucose metabolism, we treated insulin-resistant (IR) HepG2 cells with each complex. The results demonstrated that complexes 1 and 2 enhanced glucose uptake by 1.20-fold and 1.32-fold, respectively, compared to the untreated control.